The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Shilpa Gupta
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb/Medarex; Foundation Medicine; Johnson & Johnson/Janssen; Merck; Natera; Novartis; Pfizer
Research Funding - Acrivon Therapeutics (Inst); Amgen (Inst); Bristol Myers Squibb Foundation (Inst); Convergent Therapeutics (Inst); Exelixis (Inst); Flare Therapeutics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Tyra Biosciences (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate author royalty
Travel, Accommodations, Expenses - Astellas Pharma; Merck; Pfizer
 
Joep de Jong
Employment - Veracyte
Patents, Royalties, Other Intellectual Property - Decipher bladder cancer genomic classifier gene signature patent- assigned to my employer Veracyte
 
Mohammed Alshalalfa
Employment - Veracyte
Patents, Royalties, Other Intellectual Property - Bladder prostate cancer genomic classifier gene signature patent- assigned to my employer Veracyte
 
Jonathan Chou
Consulting or Advisory Role - Bicycle Therapeutics; Exai Bio; Inversion Therapeutics
Research Funding - Amgen (Inst)
 
Vadim Koshkin
Consulting or Advisory Role - Astellas Pharma; Bicycle Therapeutics; Bristol Myers Squibb Foundation; Janssen; Loxo; Merck; MSD; Natera; Pfizer; Roche/Genentech; Tempus
Research Funding - Curium Pharma (Inst); Gilead Sciences (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Pfizer/Astellas (Inst); Seagen (Inst); Taiho Oncology (Inst); Tyra Biosciences (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Pfizer
 
Terence Friedlander
Honoraria - Abbvie; Astellas Pharma; EMD Serono; Merck
Consulting or Advisory Role - AADi; Astellas Pharma; Atkis; Bicycle Therapeutics; Bristol-Myers Squibb/Medarex; EMD Serono; Gilead Sciences; Janssen; Merck; Pfizer
Research Funding - Bicycle Therapeutics; Bristol-Myers Squibb (Inst); Neon Therapeutics (Inst); Roche/Genentech (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bicycle Therapeutics; Merck
 
David Oh
Consulting or Advisory Role - Cartography Biosciences; Maze Therapeutics; Revelation Partners; Tatum Bioscience
Research Funding - Allogene Therapeutics (Inst); Amgen (Inst); Clasp Therapeutics (Inst); Merck (Inst); Nutcracker Therapeutics, Inc. (Inst); PACT Pharma (Inst); Parker Institute for Cancer Immunotherapy (Inst); Poseida Therapeutics (Inst); Roche/Genentech (Inst); TCR2 Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Inventor on patent claiming methods for the use and optimization of cytotoxic CD4+ T cell therapy for cancer.; Inventor on patent claiming methods to identify patients who will respond to or experience toxicity with cancer immunotherapies based on T cell receptor sequencing.
Travel, Accommodations, Expenses - DAVA Oncology; Poseida Therapeutics; Roche/Genentech
 
Sima Porten
Honoraria - American Urologic Association; Exact Sciences; Pacific Edge
Consulting or Advisory Role - AstraZeneca; Oncuria; Photocure; Stryker
Research Funding - Photocure (Inst)
 
Carissa Chu
No Relationships to Disclose
 
Nataliya Mar
Consulting or Advisory Role - Astellas Pharma; AVEO; EMD Serono; Exelixis; Johnson and Johnson; Pfizer
Speakers' Bureau - Eisai; Merck
Research Funding - Gilead Sciences
 
Alexander Sasse
No Relationships to Disclose
 
Anthony Wong
No Relationships to Disclose
 
James Proudfoot
Employment - Veracyte
Stock and Other Ownership Interests - Veracyte
 
Elai Davicioni
Employment - Veracyte
Stock and Other Ownership Interests - Veracyte
Patents, Royalties, Other Intellectual Property - WO2018205035A1 Decipher prostate cancer genomic classifier gene signature patent- assigned to my employer Veracyte
 
Steven Seyedin
Speakers' Bureau - Artera; Natera